股前外侧游离皮瓣重建头皮血管肉瘤:长庚医院18年经验
该单中心回顾性研究纳入2001至2018年接受扩大切除与游离皮瓣重建的头皮血管肉瘤患者8例(均为男性,平均年龄74.4岁),7例(87.5%)采用股前外侧游离皮瓣修复。所有患者接受辅助放疗,局部复发或远处转移者(各37.5%)接受化疗;2年与5年生存率分别为72.9%和38.9%。
要点
- 头皮血管肉瘤罕见且侵袭性强,扩大切除联合游离皮瓣与辅助放疗是可选方案。
- 股前外侧游离皮瓣可覆盖大面积皮肤缺损,减少对植皮的需求。
- 本组2年与5年生存率分别为72.9%和38.9%,1年与2年无病生存率均为37.5%。
核心结论
- 头皮血管肉瘤罕见且高度侵袭、预后差,股前外侧游离皮瓣是良好的重建选择。
- 包括扩大切除联合皮质刮除、辅助放疗及针对复发或转移的化疗在内的多模式治疗可能提高1年生存率(100%)。
研究设计与样本
- 单中心回顾性病历回顾,纳入2001至2018年接受扩大局部切除与游离皮瓣重建的头皮血管肉瘤患者8例(均为男性,平均年龄74.4岁)。
主要发现
- 肿瘤大小为3×3至8×13 cm,所有患者均接受扩大局部切除与外侧皮质刮除。
- 7例(87.5%)头皮缺损采用股前外侧游离皮瓣重建。
- 所有患者接受瘤床与切缘辅助放疗;局部复发(37.5%)或远处转移(37.5%)者接受化疗。
- 2年与5年生存率分别为72.9%和38.9%,1年与2年无病生存率均为37.5%。
临床怎么用
- 对可切除头皮血管肉瘤,可考虑扩大局部切除联合外侧皮质刮除,并以股前外侧游离皮瓣覆盖大面积缺损。
- 术后应常规行瘤床与切缘辅助放疗,出现局部复发或远处转移时采用化疗。
局限性
- 本研究为单中心回顾性研究,样本量仅8例,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Scalp angiosarcoma is a rare and highly aggressive cutaneous malignancy with poor prognosis and high recurrence rate. Multimodality approach is currently the treatment protocol for resectable angiosarcoma, including wide local excision and postoperative radiation. This single-institution study reviews the 18-year experience of the surgical treatment of scalp angiosarcomas. METHODS: A retrospective chart review was performed on patients with scalp angiosarcoma who received wide local excision and free flap reconstruction from 2001 to 2018. The type of free flap, safety margin, outer cortex burring, and dose for radiation were recorded. Kaplan-Meier plots were computed. RESULTS: Eight male patients (mean age of 74.4 years old) were enrolled in the series. Tumor sizes ranged from 3 × 3 to 8 × 13 cm. All patients underwent wide local excision and outer cortex burring (cortical curettage). Seven (87.5%) scalp defects were reconstructed with anterolateral thigh free flap. All patients received adjuvant radiation therapy for tumor bed and margins. Chemotherapy was adopted for the management of local recurrence (37.5%) or distant metastasis (37.5%). The 2-year and 5-year survival rates are 72.9% and 38.9%, respectively, and 1-year and 2-year disease-free rates are 37.5% each. CONCLUSION: Scalp angiosarcoma is a rare and highly aggressive cutaneous malignancy with poor prognosis. Anterolateral thigh free flap is a good reconstructive option due to its ability to cover large cutaneous defects with minimal need for skin grafting. Multimodal treatment protocol, including wide local excision with cortical curettage, and adjuvant radiation (regular basis) and chemotherapy (local recurrence or distant metastasis) may offer improved 1-year survival rate (100%).
引用
- Chou PY, Kao D, Denadai R, et al. Anterolateral thigh free flaps for the reconstruction of scalp angiosarcoma - 18-year experience in Chang Gung memorial hospital. J Plast Reconstr Aesthet Surg. 2019. PMID: 31519502. doi:10.1016/j.bjps.2019.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。